publication venue for
- The Tuberculosis Drug Accelerator at year 10: what have we learned?. 27:1333-1337. 2021
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.. 25:1505-1511. 2019
- Biomimetic 3D-printed scaffolds for spinal cord injury repair.. 25:263-269. 2019
- cGAS drives noncanonical-inflammasome activation in age-related macular degeneration.. 24:50-61. 2018
- Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats.. 22:1160-1169. 2016
- Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration.. 22:479-487. 2016
- Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.. 20:1279-1288. 2014
- Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.. 20:152-158. 2014
- Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing.. 20:75-79. 2014
- Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.. 19:809-810. 2013
- Fgf9 from dermal T cells induces hair follicle neogenesis after wounding.. 19:916-923. 2013
- Mitochondria to the rescue.. 18:653-654. 2012
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression.. 17:1231-1234. 2011
- Foxo1 integrates insulin signaling with mitochondrial function in the liver.. 15:1307-1311. 2009
- Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.. 12:1027-1029. 2006
- Bone loss goes beyond estrogen.. 12:612-613. 2006
- Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.. 12:908-916. 2006
- Cadmium's disguise dupes the estrogen receptor.. 9:1000-1001. 2003
- Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.. 5:309-313. 1999
- Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy.. 4:1269-1275. 1998
- Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis (vol 17, pg 1242, 2011). 17:1521-1521.
- Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.. 17:1242-1250.
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.. 17:55-63.
- Striking a balance in fragile X.. 19:1370-1371.
- Wireless bioresorbable electronic system enables sustained nonpharmacological neuroregenerative therapy.. 24:1830-1836.